Opening book details…
About this book
Spironolactone versus placebo in patients undergoing maintenance dialysis (ACHIEVE): an international, parallel-group, randomised controlled trial by Michael Walsh MD PhD & David Collister MD PhD & Martin Gallagher MBChB PhD & Patrick B Mark MBChB PhD & Janak R de Zoysa MBChB MClinEd & Jessica Tyrwhitt BSc & Karthik Tennankore MD MSc & Gilmar Reis MD PhD & Denis Xavier MD PhD & Wen J Liu MBChB & Li... is a book available to read on EtoBox.
- Author
- Michael Walsh MD PhD & David Collister MD PhD & Martin Gallagher MBChB PhD & Patrick B Mark MBChB PhD & Janak R de Zoysa MBChB MClinEd & Jessica Tyrwhitt BSc & Karthik Tennankore MD MSc & Gilmar Reis MD PhD & Denis Xavier MD PhD & Wen J Liu MBChB & Li...
- Publisher
- x
- Published
- 2025
- Language
- EN
More by Michael Walsh MD PhD & David Collister MD PhD & Martin Gallagher MBChB PhD & Patrick B Mark MBChB PhD & Janak R de Zoysa MBChB MClinEd & Jessica Tyrwhitt BSc & Karthik Tennankore MD MSc & Gilmar Reis MD PhD & Denis Xavier MD PhD & Wen J Liu MBChB & Li...
Similar books
- Exenatide Once a Week Versus Placebo as a Potential Disease-modifying Treatment for People with Parkinson's Disease in the UK: a Phase 3, Multicentre, Double-blind, Parallel-group, Randomised, Placebo-controlled Trial — Nirosen Vijiaratnam MD & Christine Girges PhD & Grace Auld MSc & Rachel McComish MSc & Alexa King BA & Prof Simon S Skene PhD & Steve Hibbert MBA & Alan Wong MSc & Sabina Melander BSc & Rachel Gibson BSc & Helen Matthews MA & John Dickson PhD & Prof... (2025)
- Safety and Efficacy of Once-weekly Efruxifermin Versus Placebo in Metabolic Dysfunction-associated Steatohepatitis (HARMONY): 96-week Results from a Multicentre, Randomised, Double-blind, Placebo-controlled, Phase 2b Trial — Prof Mazen Noureddin MD & Juan P Frias MD & Guy W Neff MD & K Jean Lucas MD & Cynthia Behling MD & Pierre Bedossa MD & Julie Dubourg MD & Doreen Chan PhD & Mark Burch PhD & Erica Fong BS & Brittany de Temple BS & Matt Minerva BS & Kim Barrett BS &... (2025)
- Spironolactone in Patients on Chronic Haemodialysis at High Risk of Adverse Cardiovascular Outcomes (ALCHEMIST): a Multicentre, Double-blind, Randomised, Placebo-controlled Trial and Updated Meta-analysis — Prof Patrick Rossignol MD & Prof Faiez Zannad MD & Prof Ziad Massy MD & Prof Michel Azizi MD & Fatima Chorfa MSc & Julien Coadic BSc & João Pedro Ferreira MD & Francisca Saraiva PhD & Prof Dominique Mottier MD & Prof Francis Guillemin MD & Willy... (2025)
- Guselkumab in Patients with Moderately to Severely Active Ulcerative Colitis (QUASAR): Phase 3 Double-blind, Randomised, Placebo-controlled Induction and Maintenance Studies — David T Rubin MD & Jessica R Allegretti MD & Julián Panés MD & Nicole Shipitofsky PharmD & Shadi S Yarandi MD & Kuan-Hsiang Gary Huang MD & Matthew Germinaro MD & Rebbecca Wilson DrPH & Hongyan Zhang PhD & Jewel Johanns PhD & Brian G Feagan MD &... (2024)
- Paclitaxel-coated Versus Uncoated Devices for Infrainguinal Endovascular Revascularisation in Patients with Intermittent Claudication (SWEDEPAD 2): a Multicentre, Participant-masked, Registry-based, Randomised Controlled Trial — Prof Joakim Nordanstig MD PhD & Prof Stefan James MD PhD & Manne Andersson MD PhD & Mattias Andersson MD & Martin Delle MD PhD & Jan Engström MD & Torbjörn Fransson MD PhD & Peter Gillgren MD PhD & Anna Hilbertson MD & Tal M Hörer MD PhD & Eva... (2025)
- Surgery Versus Corticosteroid Injection for Carpal Tunnel Syndrome (DISTRICTS): an Open-label, Multicentre, Randomised Controlled Trial — Wijnand A C Palmbergen MD & Roy Beekman MD & A Marijne Heeren PhD & Bart F L van Nuenen MD & Tim W H Alleman MD & Esther Verstraete MD & Korné Jellema MD & Wim I M Verhagen MD & Prof Leo H Visser MD & Godard C W de Ruiter MD & Prof Diederik van de... (2025)